Asthma, rhinitis, and atopic dermatitis (AD) are interrelated clinical phenotypes that partly
overlap in the human interactome. The concept of “one‐airway‐one‐disease,” coined over …

Allergic rhinitis (AR) is caused by immunoglobulin E (IgE)-mediated reactions to inhaled
allergens and is one of the most common chronic conditions globally. AR often co-occurs …

One hundred and ten years after Noon's first clinical report of the subcutaneous application
of allergen extracts, allergen immunotherapy (AIT) has evolved as the most important pillar …

Background Validated combined symptom‐medication scores (CSMSs) are needed to
investigate the effects of allergic rhinitis treatments. This study aimed to use real‐life data …

Increase of allergic conditions has occurred at the same pace with the Great Acceleration,
which stands for the rapid growth rate of human activities upon earth from 1950s. Changes …

Introduction In allergic asthma patients, one of the more common phenotypes might benefit
from allergen immunotherapy (AIT) as add‐on intervention to pharmacological treatment …

Background MASK‐air® is an app that supports allergic rhinitis patients in disease control.
Users register daily allergy symptoms and their impact on activities using visual analog …

MASK‐air®, a validated mHealth app (Medical Device regulation Class IIa) has enabled
large observational implementation studies in over 58,000 people with allergic rhinitis …

Portable devices, such as smartphones and mobile Internet access have become ubiquitous
in the last decades. The term 'eHealth'stands for electronic health. The tools included in the …

Background Co‐medication is common among patients with allergic rhinitis (AR), but its
dimension and patterns are unknown. This is particularly relevant since AR is understood …